Nevirapine and tuberculosis predict first-line treatment failure in HIV patients in Indonesia: Case-control study
- PMID: 33133585
- PMCID: PMC7584999
- DOI: 10.1016/j.amsu.2020.10.005
Nevirapine and tuberculosis predict first-line treatment failure in HIV patients in Indonesia: Case-control study
Abstract
Introduction: Indonesia antiretroviral therapy guideline suggests the use of Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-based regiments as first line of HIV treatment and Protease Inhibitor to replace NNRTI when treatment failure occurred. This case-control study was aimed to study factors predicting first-line ART treatment failure among HIV positive patients aged >15 years, non-pregnant, and registered in our institution, Indonesia.
Methods: Diagnosis of HIV treatment failure was made according to the standard WHO criteria. Demographic and outcome variables were recorded. The association between variables were analyzed by Chi-square test with odds ratios (OR) and 95% confidence intervals (95% CI), followed by multivariate analysis using logistic regression test.
Results: Twenty-six index cases and 26 age- and sex-matched control cases were included in the study with a mean age of 32.27 ± 8.7 years and 32.88 ± 8.15 years, respectively. Median time for switching to second-line (Lopinavir/ritonavir, LPV/r) was 46.32 ± 30.21 months. Patients presented with tuberculosis and treated by nevirapine as the first-line treatment were 26.6-folds (95% CI: 2.41-293.81, p = 0.007) and 6.7-folds (95% CI: 1.56-28.45, p = 0.011) higher risk for treatment failure, respectively.
Conclusions: The presence of tuberculosis and the use of nevirapine in first-line treatment were strong predictors for first-line ARV treatment failure, suggesting for closer clinical monitoring for patients with those conditions. A further and larger prospective cohort study is needed to confirm the findings in this study.
Keywords: ART treatment failure; HIV; Indonesia; Nevirapine; Predicting factors; Tuberculosis.
© 2020 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
Conflict of interest statement
The authors declared no potential conflicts of interest.
Similar articles
-
First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting.AIDS. 2014 May 15;28(8):1143-53. doi: 10.1097/QAD.0000000000000214. AIDS. 2014. PMID: 25028911 Free PMC article. Clinical Trial.
-
Induction with lopinavir-based treatment followed by switch to nevirapine-based regimen versus non-nucleoside reverse transcriptase inhibitors-based treatment for first line antiretroviral therapy in HIV infected children three years and older.PLoS One. 2014 Sep 18;9(9):e108063. doi: 10.1371/journal.pone.0108063. eCollection 2014. PLoS One. 2014. PMID: 25232730 Free PMC article.
-
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.BMC Med. 2017 Apr 24;15(1):85. doi: 10.1186/s12916-017-0842-4. BMC Med. 2017. PMID: 28434406 Free PMC article. Clinical Trial.
-
Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.BMC Pediatr. 2014 Feb 12;14:39. doi: 10.1186/1471-2431-14-39. BMC Pediatr. 2014. PMID: 24521425 Free PMC article. Clinical Trial.
-
Lopinavir/ritonavir: a review of its use in the management of HIV infection.Drugs. 2003;63(8):769-802. doi: 10.2165/00003495-200363080-00004. Drugs. 2003. PMID: 12662125 Review.
Cited by
-
Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naïve patients in Northern Vietnam from 2019 to 2022.Glob Health Med. 2024 Apr 30;6(2):117-123. doi: 10.35772/ghm.2023.01112. Glob Health Med. 2024. PMID: 38690128 Free PMC article.
-
Methicillin resistance Staphylococcus aureus nasal carriage and its associated factors among HIV patients attending art clinic at Dessie comprehensive specialized hospital, Dessie, North East Ethiopia.PLOS Glob Public Health. 2022 Sep 12;2(9):e0000838. doi: 10.1371/journal.pgph.0000838. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962756 Free PMC article.
References
-
- Who . 2013 June. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach June 2013. - PubMed
-
- UNAIDS . e; 2018. Miles to go: closing gaps, breaking barrier, righting justic.https://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf Available from:
-
- Agha R., Abdall-Razak A., Crossley E., Dowlut N., Iosifidis C., Mathew G. STROCSS 2019 Guideline: strengthening the reporting of cohort studies in surgery. Int. J. Surg. 2019;72:156–165. - PubMed
LinkOut - more resources
Full Text Sources